Researchers have found that melanoma cells fight anti-cancer drugs by changing their internal skeleton (cytoskeleton) — opening up a new therapeutic route for combating skin and other cancers that develop resistance to treatment.
Researchers have found that melanoma cells fight anti-cancer drugs by changing their internal skeleton (cytoskeleton) — opening up a new therapeutic route for combating skin and other cancers that develop resistance to treatment.